Misplaced Pages

#77922

86-421: Mammalian genomes have two separate SREBP genes ( SREBF1 and SREBF2 ): SREB proteins are indirectly required for cholesterol biosynthesis and for uptake and fatty acid biosynthesis. These proteins work with asymmetric sterol regulatory element (StRE). SREBPs have a structure similar to E-box -binding helix-loop-helix (HLH) proteins. However, in contrast to E-box-binding HLH proteins, an arginine residue

172-427: A class A repeat or LDL-A , contains roughly 40 amino acids, including 6 cysteine residues that form disulfide bonds within the repeat. Additionally, each repeat has highly conserved acidic residues which it uses to coordinate a single calcium ion in an octahedral lattice. Both the disulfide bonds and calcium coordination are necessary for the structural integrity of the domain during the receptor's repeated trips to

258-437: A myelin sheath, rich in cholesterol since it is derived from compacted layers of Schwann cell or oligodendrocyte membranes, provides insulation for more efficient conduction of impulses. Demyelination (loss of myelin) is believed to be part of the basis for multiple sclerosis . Cholesterol binds to and affects the gating of a number of ion channels such as the nicotinic acetylcholine receptor , GABA A receptor , and

344-428: A cell via endocytosis . These vesicles then fuse with a lysosome , where the lysosomal acid lipase enzyme hydrolyzes the cholesterol esters. The cholesterol can then be used for membrane biosynthesis or esterified and stored within the cell, so as to not interfere with the cell membranes. LDL receptors are used up during cholesterol absorption, and its synthesis is regulated by SREBP , the same protein that controls

430-412: A change in this domain's oligomerization state, which makes it more susceptible to destruction by the proteasome . This enzyme's activity can also be reduced by phosphorylation by an AMP-activated protein kinase . Because this kinase is activated by AMP, which is produced when ATP is hydrolyzed, it follows that cholesterol synthesis is halted when ATP levels are low. As an isolated molecule, cholesterol

516-466: A lower intake of food has the opposite effect. The main regulatory mechanism is the sensing of intracellular cholesterol in the endoplasmic reticulum by the protein SREBP (sterol regulatory element-binding protein 1 and 2). In the presence of cholesterol, SREBP is bound to two other proteins: SCAP (SREBP cleavage-activating protein) and INSIG-1 . When cholesterol levels fall, INSIG-1 dissociates from

602-412: A precursor for other compounds, such as phytosterols and steroidal glycoalkaloids , with cholesterol remaining in plant foods only in minor amounts or absent. Some plant foods, such as avocado , flax seeds and peanuts , contain phytosterols, which compete with cholesterol for absorption in the intestines and reduce the absorption of both dietary and bile cholesterol. A typical diet contributes on

688-645: A tissue specific manner the expression of PGC1alpha expression in brown adipose tissue. Nur77 is suggested to inhibit LXR and downstream SREBP-1c expression modulating hepatic lipid metabolism. The SREBPs were elucidated in the laboratory of Nobel laureates Michael Brown and Joseph Goldstein at the University of Texas Southwestern Medical Center in Dallas. Their first publication on this subject appeared in October 1993. Cholesterol Cholesterol

774-639: A way as to bind large steroid substrates like cholesterol. Animal fats are complex mixtures of triglycerides , with lesser amounts of both the phospholipids and cholesterol molecules from which all animal (and human) cell membranes are constructed. Since all animal cells manufacture cholesterol, all animal-based foods contain cholesterol in varying amounts. Major dietary sources of cholesterol include red meat , egg yolks and whole eggs , liver , kidney , giblets , fish oil , shellfish, and butter . Human breast milk also contains significant quantities of cholesterol. Plant cells synthesize cholesterol as

860-547: Is a mosaic protein of 839 amino acids (after removal of 21-amino acid signal peptide ) that mediates the endocytosis of cholesterol-rich low-density lipoprotein (LDL). It is a cell-surface receptor that recognizes apolipoprotein B100 (ApoB100), which is embedded in the outer phospholipid layer of very low-density lipoprotein (VLDL), their remnants—i.e. intermediate-density lipoprotein (IDL), and LDL particles. The receptor also recognizes apolipoprotein E (ApoE) which

946-429: Is absent among prokaryotes ( bacteria and archaea ), although there are some exceptions, such as Mycoplasma , which require cholesterol for growth. Cholesterol also serves as a precursor for the biosynthesis of steroid hormones , bile acid and vitamin D . Elevated levels of cholesterol in the blood, especially when bound to low-density lipoprotein (LDL, often referred to as "bad cholesterol"), may increase

SECTION 10

#1732798272078

1032-407: Is also implicated in cell signaling processes, assisting in the formation of lipid rafts in the plasma membrane , which brings receptor proteins in close proximity with high concentrations of second messenger molecules. In multiple layers, cholesterol and phospholipids, both electrical insulators, can facilitate speed of transmission of electrical impulses along nerve tissue. For many neuron fibers,

1118-466: Is associated with atheromatous disease progression in the arteries. Cholesterol is susceptible to oxidation and easily forms oxygenated derivatives called oxysterols . Three different mechanisms can form these: autoxidation, secondary oxidation to lipid peroxidation, and cholesterol-metabolizing enzyme oxidation. A great interest in oxysterols arose when they were shown to exert inhibitory actions on cholesterol biosynthesis. This finding became known as

1204-775: Is found in chylomicron remnants and IDL. In humans, the LDL receptor protein is encoded by the LDLR gene on chromosome 19 . It belongs to the low density lipoprotein receptor gene family . It is most significantly expressed in bronchial epithelial cells and adrenal gland and cortex tissue. Michael S. Brown and Joseph L. Goldstein were awarded the 1985 Nobel Prize in Physiology or Medicine for their identification of LDL-R and its relation to cholesterol metabolism and familial hypercholesterolemia . Disruption of LDL-R can lead to higher LDL-cholesterol as well as increasing

1290-666: Is identical, although some is carried as its native "free" alcohol form (the cholesterol-OH group facing the water surrounding the particles), while others as fatty acyl esters, known also as cholesterol esters, within the particles. Lipoprotein particles are organized by complex apolipoproteins , typically 80–100 different proteins per particle, which can be recognized and bound by specific receptors on cell membranes, directing their lipid payload into specific cells and tissues currently ingesting these fat transport particles. These surface receptors serve as unique molecular signatures, which then help determine fat distribution delivery throughout

1376-537: Is not sufficient to stimulate hepatic SREBP-1c in the absence of Akt signaling , revealing the existence of an additional downstream pathway also required for this induction which is proposed to involve mTORC1-independent Akt-mediated suppression of INSIG-2a , a liver-specific transcript encoding the SREBP-1c inhibitor INSIG2. FGF21 has been shown to repress the transcription of sterol regulatory element binding protein 1c (SREBP-1c). Overexpression of FGF21 ameliorated

1462-437: Is of low abundance in lipid rafts. PC localizes to the disordered region of the cell along with the polyunsaturated lipid phosphatidylinositol 4,5-bisphosphate (PIP2). PLD2 has a PIP2 binding domain . When PIP2 concentration in the membrane increases, PLD2 leaves the cholesterol-dependent domains and binds to PIP2 where it then gains access to its substrate PC and commences catalysis based on substrate presentation. Cholesterol

1548-423: Is only minimally soluble in water , or hydrophilic . Because of this, it dissolves in blood at exceedingly small concentrations. To be transported effectively, cholesterol is instead packaged within lipoproteins , complex discoidal particles with exterior amphiphilic proteins and lipids, whose outward-facing surfaces are water-soluble and inward-facing surfaces are lipid-soluble. This allows it to travel through

1634-446: Is oxidized by the liver into a variety of bile acids . These, in turn, are conjugated with glycine , taurine , glucuronic acid , or sulfate . A mixture of conjugated and nonconjugated bile acids, along with cholesterol itself, is excreted from the liver into the bile . Approximately 95% of the bile acids are reabsorbed from the intestines, and the remainder are lost in the feces. The excretion and reabsorption of bile acids forms

1720-427: Is replaced with tyrosine making them capable of recognizing StREs and thereby regulating membrane biosynthesis. Animal cells maintain proper levels of intracellular lipids (fats and oils) under widely varying circumstances (lipid homeostasis ). For example, when cellular cholesterol levels fall below the level needed, the cell makes more of the enzymes necessary to make cholesterol. A principal step in this response

1806-403: Is required to build and maintain membranes and modulates membrane fluidity over the range of physiological temperatures. The hydroxyl group of each cholesterol molecule interacts with water molecules surrounding the membrane, as do the polar heads of the membrane phospholipids and sphingolipids , while the bulky steroid and the hydrocarbon chain are embedded in the membrane, alongside

SECTION 20

#1732798272078

1892-476: Is taken up from here to the bloodstream by the liver. VLDL particles are produced by the liver from triacylglycerol and cholesterol which was not used in the synthesis of bile acids. These particles contain apolipoprotein B100 and apolipoprotein E in their shells and can be degraded by lipoprotein lipase on the artery wall to IDL. This arterial wall cleavage allows absorption of triacylglycerol and increases

1978-456: Is the principal sterol of all higher animals , distributed in body tissues , especially the brain and spinal cord , and in animal fats and oils . Cholesterol is biosynthesized by all animal cells and is an essential structural and signaling component of animal cell membranes . In vertebrates , hepatic cells typically produce the greatest amounts. In the brain, astrocytes produce cholesterol and transport it to neurons . It

2064-494: Is then reduced to mevalonate by the enzyme HMG-CoA reductase . Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins (a class of cholesterol-lowering drugs). Mevalonate is finally converted to isopentenyl pyrophosphate (IPP) through two phosphorylation steps and one decarboxylation step that requires ATP . Three molecules of isopentenyl pyrophosphate condense to form farnesyl pyrophosphate through

2150-493: Is to make more of the mRNA transcripts that direct the synthesis of these enzymes . Conversely, when there is enough cholesterol around, the cell stops making those mRNAs and the level of the enzymes falls. As a result, the cell quits making cholesterol once it has enough. A notable feature of this regulatory feedback machinery was first observed for the SREBP pathway - regulated intramembrane proteolysis (RIP). Subsequently, RIP

2236-550: Is transported to the Golgi. The regulation of SREBP cleavage employs a notable feature of eukaryotic cells , subcellular compartmentalization defined by intracellular membranes, to ensure that cleavage occurs only when needed. Once in the Golgi apparatus, the SREBP-SCAP complex encounters active S1P. S1P cleaves SREBP at site-1, cutting it into two halves. Because each half still has a membrane-spanning helix, each remains bound in

2322-473: The GI tract , an important protective mechanism. The intake of naturally occurring phytosterols, which encompass plant sterols and stanols , ranges between ≈200–300 mg/day depending on eating habits. Specially designed vegetarian experimental diets have been produced yielding upwards of 700 mg/day. Cholesterol is present in varying degrees in all animal cell membranes , but is absent in prokaryotes. It

2408-479: The Nobel Prize in Physiology or Medicine in 1964 for their discoveries concerning some of the mechanisms and methods of regulation of cholesterol and fatty acid metabolism . Biosynthesis of cholesterol is directly regulated by the cholesterol levels present, though the homeostatic mechanisms involved are only partly understood. A higher intake of food leads to a net decrease in endogenous production, whereas

2494-490: The calcium metabolism and all steroid hormones , including the adrenal gland hormones cortisol and aldosterone , as well as the sex hormones progesterone , estrogens , and testosterone , and their derivatives. The stratum corneum is the outermost layer of the epidermis. It is composed of terminally differentiated and enucleated corneocytes that reside within a lipid matrix, like "bricks and mortar." Together with ceramides and free fatty acids, cholesterol forms

2580-498: The endocytosis of cholesterol-rich LDL and thus maintains the plasma level of LDL. This occurs in all nucleated cells, but mainly in the liver which removes ~70% of LDL from the circulation. LDL receptors are clustered in clathrin -coated pits, and coated pits pinch off from the surface to form coated endocytic vesicles that carry LDL into the cell. After internalization , the receptors dissociate from their ligands when they are exposed to lower pH in endosomes . After dissociation,

2666-468: The endoplasmic reticulum and are modified by the Golgi apparatus before travelling in vesicles to the cell surface. In humans, LDL is directly involved in the development of atherosclerosis , which is the process responsible for the majority of cardiovascular diseases , due to accumulation of LDL-cholesterol in the blood . Hyperthyroidism may be associated with reduced cholesterol via upregulation of

Sterol regulatory element-binding protein - Misplaced Pages Continue

2752-552: The gallbladder , which then excretes them in a non- esterified form (via bile) into the digestive tract. Typically, about 50% of the excreted cholesterol is reabsorbed by the small intestine back into the bloodstream. Almost all animal tissues synthesize cholesterol from acetyl-CoA . All animal cells (exceptions exist within the invertebrates) manufacture cholesterol, for both membrane structure and other uses, with relative production rates varying by cell type and organ function. About 80% of total daily cholesterol production occurs in

2838-406: The inward-rectifier potassium channel . Cholesterol also activates the estrogen-related receptor alpha (ERRα), and may be the endogenous ligand for the receptor . The constitutively active nature of the receptor may be explained by the fact that cholesterol is ubiquitous in the body. Inhibition of ERRα signaling by reduction of cholesterol production has been identified as a key mediator of

2924-441: The liver and the intestines ; other sites of higher synthesis rates include the brain , the adrenal glands , and the reproductive organs . Synthesis within the body starts with the mevalonate pathway where two molecules of acetyl CoA condense to form acetoacetyl-CoA . This is followed by a second condensation between acetyl CoA and acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl CoA ( HMG-CoA ). This molecule

3010-454: The nonpolar fatty-acid chain of the other lipids. Through the interaction with the phospholipid fatty-acid chains, cholesterol increases membrane packing, which both alters membrane fluidity and maintains membrane integrity so that animal cells do not need to build cell walls (like plants and most bacteria). The membrane remains stable and durable without being rigid, allowing animal cells to change shape and animals to move. The structure of

3096-423: The tetracyclic ring of cholesterol contributes to the fluidity of the cell membrane, as the molecule is in a trans conformation making all but the side chain of cholesterol rigid and planar. In this structural role, cholesterol also reduces the permeability of the plasma membrane to neutral solutes, hydrogen ions, and sodium ions. Cholesterol regulates the biological process of substrate presentation and

3182-511: The "oxysterol hypothesis". Additional roles for oxysterols in human physiology include their participation in bile acid biosynthesis, function as transport forms of cholesterol, and regulation of gene transcription. In biochemical experiments, radiolabelled forms of cholesterol, such as tritiated-cholesterol, are used. These derivatives undergo degradation upon storage, and it is essential to purify cholesterol prior to use. Cholesterol can be purified using small Sephadex LH-20 columns. Cholesterol

3268-658: The 1.6–3.0 grams per day range (Health Canada, EFSA, ATP III, FDA). A meta-analysis demonstrated a 12% reduction in LDL-cholesterol at a mean dose of 2.1 grams per day. The benefits of a diet supplemented with phytosterols have also been questioned. According to the lipid hypothesis , elevated levels of cholesterol in the blood lead to atherosclerosis which may increase the risk of heart attack , stroke , and peripheral artery disease . Since higher blood LDL – especially higher LDL concentrations and smaller LDL particle size – contributes to this process more than

3354-557: The 2015 iteration of the Dietary Guidelines for Americans dropped the previously recommended limit of consumption of dietary cholesterol to 300 mg per day with a new recommendation to "eat as little dietary cholesterol as possible", thereby acknowledging an association between a diet low in cholesterol and reduced risk of cardiovascular disease. A 2013 report by the American Heart Association and

3440-693: The American College of Cardiology recommended focusing on healthy dietary patterns rather than specific cholesterol limits, as they are hard for clinicians and consumers to implement. They recommend the DASH and Mediterranean diet , which are low in cholesterol. A 2017 review by the American Heart Association recommends switching saturated fats for polyunsaturated fats to reduce cardiovascular disease risk. Some supplemental guidelines have recommended doses of phytosterols in

3526-758: The EGF precursor gene. There are three "growth factor" repeats; A, B and C. A and B are closely linked while C is separated by the YWTD repeat region, which adopts a beta-propeller conformation (LDL-R class B domain ). It is thought that this region is responsible for the pH-dependent conformational shift that causes bound LDL to be released in the endosome . A third domain of the protein is rich in O-linked oligosaccharides but appears to show little function. Knockout experiments have confirmed that no significant loss of activity occurs without this domain. It has been speculated that

Sterol regulatory element-binding protein - Misplaced Pages Continue

3612-510: The ER membrane and thus the SREBP-SCAP complex remains in the ER when SCAP is bound to INSIG. When sterol levels are low, INSIG and SCAP no longer bind. Then, SCAP undergoes a conformational change that exposes a portion of the protein ('MELADL') that signals it to be included as cargo in the COPII vesicles that move from the ER to the Golgi apparatus. In these vesicles, SCAP, dragging SREBP along with it,

3698-1069: The IDEAL and the EPIC prospective studies found an association between high levels of HDL cholesterol (adjusted for apolipoprotein A-I and apolipoprotein B) and increased risk of cardiovascular disease, casting doubt on the cardioprotective role of "good cholesterol". LDL receptor 1AJJ , 1D2J , 1F5Y , 1HJ7 , 1HZ8 , 1I0U , 1IJQ , 1LDL , 1LDR , 1N7D , 1XFE , 2FCW , 2KRI , 2LGP , 2W2M , 2W2N , 2W2O , 2W2P , 2W2Q , 3BPS , 3GCW , 3GCX , 3M0C , 3SO6 , 2M7P , 2MG9 , 3P5B , 3P5C , 4NE9 3949 16835 ENSG00000130164 ENSMUSG00000032193 P01130 P35951 NM_001195803 NM_001252658 NM_001252659 NM_010700 NP_000518 NP_001182727 NP_001182728 NP_001182729 NP_001182732 NP_001239587 NP_001239588 NP_034830 The low-density lipoprotein receptor ( LDL-R )

3784-494: The LDL receptor, and hypothyroidism with the converse. A vast number of studies have described the relevance of LDL receptors in the pathophysiology of atherosclerosis, metabolic syndrome, and steatohepatitis. Previously, rare mutations in LDL-genes have been shown to contribute to myocardial infarction risk in individual families, whereas common variants at more than 45 loci have been associated with myocardial infarction risk in

3870-445: The SREBP pathway regulates the expression of many genes that control lipid formation and metabolism and body fuel allocation. Cholesterol synthesis can also be turned off when cholesterol levels are high. HMG-CoA reductase contains both a cytosolic domain (responsible for its catalytic function) and a membrane domain. The membrane domain senses signals for its degradation. Increasing concentrations of cholesterol (and other sterols) cause

3956-415: The SREBP-1c gene via the mTORC1 / S6K1 pathway. The phosphorylation of S6K1 was increased in the liver of obese db/db mice. Furthermore, depletion of hepatic S6K1 in db/db mice with the use of an adenovirus vector encoding S6K1 shRNA resulted in down-regulation of SREBP-1c gene expression in the liver as well as a reduced hepatic triglyceride content and serum triglyceride concentration. mTORC1 activation

4042-435: The SREBP-SCAP complex, which allows the complex to migrate to the Golgi apparatus . Here SREBP is cleaved by S1P and S2P (site-1 protease and site-2 protease), two enzymes that are activated by SCAP when cholesterol levels are low. The cleaved SREBP then migrates to the nucleus and acts as a transcription factor to bind to the sterol regulatory element (SRE), which stimulates the transcription of many genes. Among these are

4128-614: The SREBP1c expression, particularly in rodents. Serial deletion and mutation assays reveal that both SREBP (SRE) and LXR (LXRE) response elements are involved in SREBP-1c transcription regulation mediated by insulin and cholesterol derivatives. Peroxisome proliferation-activated receptor alpha ( PPARα ) agonists enhance the activity of the SREBP-1c promoter via a DR1 element at -453 in the human promoter. PPARα agonists act in cooperation with LXR or insulin to induce lipogenesis. A medium rich in branched-chain amino acids stimulates expression of

4214-791: The action of geranyl transferase. Two molecules of farnesyl pyrophosphate then condense to form squalene by the action of squalene synthase in the endoplasmic reticulum . Oxidosqualene cyclase then cyclizes squalene to form lanosterol . Finally, lanosterol is converted to cholesterol via either of two pathways, the Bloch pathway, or the Kandutsch-Russell pathway. The final 19 steps to cholesterol contain NADPH and oxygen to help oxidize methyl groups for removal of carbons, mutases to move alkene groups, and NADH to help reduce ketones . Konrad Bloch and Feodor Lynen shared

4300-572: The association more pronounced in younger subjects. Because cardiovascular disease is relatively rare in the younger population, the impact of high cholesterol on health is larger in older people. Elevated levels of the lipoprotein fractions, LDL, IDL and VLDL, rather than the total cholesterol level, correlate with the extent and progress of atherosclerosis. Conversely, the total cholesterol can be within normal limits, yet be made up primarily of small LDL and small HDL particles, under which conditions atheroma growth rates are high. A post hoc analysis of

4386-407: The association of so-called LDL cholesterol (actually a lipoprotein ) with "bad" cholesterol. HDL particles are thought to transport cholesterol back to the liver, either for excretion or for other tissues that synthesize hormones, in a process known as reverse cholesterol transport (RCT). Large numbers of HDL particles correlates with better health outcomes, whereas low numbers of HDL particles

SECTION 50

#1732798272078

4472-415: The band 19p13.2 and is split into 18 exons . Exon 1 contains a signal sequence that localises the receptor to the endoplasmic reticulum for transport to the cell surface. Beyond this, exons 2-6 code the ligand binding region; 7-14 code the epidermal growth factor (EGF) domain; 15 codes the oligosaccharide rich region; 16 (and some of 17) code the membrane spanning region; and 18 (with the rest of 17) code

4558-428: The basis of the enterohepatic circulation , which is essential for the digestion and absorption of dietary fats. Under certain circumstances, when more concentrated, as in the gallbladder , cholesterol crystallises and is the major constituent of most gallstones ( lecithin and bilirubin gallstones also occur, but less frequently). Every day, up to 1 g of cholesterol enters the colon. This cholesterol originates from

4644-701: The blood via emulsification . Unbound cholesterol, being amphipathic, is transported in the monolayer surface of the lipoprotein particle along with phospholipids and proteins. Cholesterol esters bound to fatty acid, on the other hand, are transported within the fatty hydrophobic core of the lipoprotein, along with triglyceride. There are several types of lipoproteins in the blood. In order of increasing density, they are chylomicrons , very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL). Lower protein/lipid ratios make for less dense lipoproteins. Cholesterol within different lipoproteins

4730-399: The blood. Surprisingly, in rats, blood cholesterol is inversely correlated with cholesterol consumption. The more cholesterol a rat eats the lower the blood cholesterol. During the first seven hours after ingestion of cholesterol, as absorbed fats are being distributed around the body within extracellular water by the various lipoproteins (which transport all fats in the water outside cells),

4816-469: The blood. These LDL particles are oxidized and taken up by macrophages , which become engorged and form foam cells. These foam cells often become trapped in the walls of blood vessels and contribute to atherosclerotic plaque formation. Differences in cholesterol homeostasis affect the development of early atherosclerosis (carotid intima-media thickness). These plaques are the main causes of heart attacks, strokes, and other serious medical problems, leading to

4902-468: The body. Chylomicrons, the least dense cholesterol transport particles, contain apolipoprotein B-48 , apolipoprotein C , and apolipoprotein E (the principal cholesterol carrier in the brain ) in their shells. Chylomicrons carry fats from the intestine to muscle and other tissues in need of fatty acids for energy or fat production. Unused cholesterol remains in more cholesterol-rich chylomicron remnants and

4988-515: The brain. De novo synthesis, both in astrocytes and hepatocytes, occurs by a complex 37-step process. This begins with the mevalonate or HMG-CoA reductase pathway , the target of statin drugs, which encompasses the first 18 steps. This is followed by 19 additional steps to convert the resulting lanosterol into cholesterol. A human male weighing 68 kg (150 lb) normally synthesizes about 1 gram (1,000 mg) of cholesterol per day, and his body contains about 35 g, mostly contained within

5074-513: The cell membranes. Typical daily cholesterol dietary intake for a man in the United States is 307 mg. Most ingested cholesterol is esterified , which causes it to be poorly absorbed by the gut. The body also compensates for absorption of ingested cholesterol by reducing its own cholesterol synthesis. For these reasons, cholesterol in food, seven to ten hours after ingestion, has little, if any effect on concentrations of cholesterol in

5160-573: The cholesterol content of the HDL particles, LDL particles are often termed "bad cholesterol". High concentrations of functional HDL, which can remove cholesterol from cells and atheromas, offer protection and are commonly referred to as "good cholesterol". These balances are mostly genetically determined, but can be changed by body composition, medications , diet, and other factors. A 2007 study demonstrated that blood total cholesterol levels have an exponential effect on cardiovascular and total mortality, with

5246-710: The concentration of circulating cholesterol. IDL particles are then consumed in two processes: half is metabolized by HTGL and taken up by the LDL receptor on the liver cell surfaces, while the other half continues to lose triacylglycerols in the bloodstream until they become cholesterol-laden LDL particles. LDL particles are the major blood cholesterol carriers. Each one contains approximately 1,500 molecules of cholesterol ester. LDL particle shells contain just one molecule of apolipoprotein B100 , recognized by LDL receptors in peripheral tissues. Upon binding of apolipoprotein B100 , many LDL receptors concentrate in clathrin -coated pits. Both LDL and its receptor form vesicles within

SECTION 60

#1732798272078

5332-421: The concentrations increase. Plants make cholesterol in very small amounts. In larger quantities they produce phytosterols , chemically similar substances which can compete with cholesterol for reabsorption in the intestinal tract, thus potentially reducing cholesterol reabsorption. When intestinal lining cells absorb phytosterols, in place of cholesterol, they usually excrete the phytosterol molecules back into

5418-400: The control regions of the genes that encode enzymes needed to make lipids. This binding to DNA leads to the increased transcription of the target genes . The ~120 kDa SREBP precursor protein is anchored in the membranes of the endoplasmic reticulum (ER) and nuclear envelope by virtue of two membrane-spanning helices in the middle of the protein . The precursor has a hairpin orientation in

5504-499: The cytosolic domain. This gene produces 6 isoforms through alternative splicing. This protein belongs to the LDLR family and is made up of a number of functionally distinct domains , including 3 EGF-like domains, 7 LDL-R class A domains, and 6 LDL-R class B repeats. The N-terminal domain of the LDL receptor, which is responsible for ligand binding, is composed of seven sequence repeats (~50% identical). Each repeat, referred to as

5590-476: The cytosolic sequence have been found in other lipoprotein receptors, as well as in more distant receptor relatives. Loss-of-function mutations in the gene encoding the LDL receptor are known to cause familial hypercholesterolaemia. There are 5 broad classes of mutation of the LDL receptor: Gain-of-function mutations decrease LDL levels and are a target of research to develop a gene therapy to treat refractory hypercholesterolemia. LDL receptor mediates

5676-567: The diet, bile, and desquamated intestinal cells, and it can be metabolized by the colonic bacteria. Cholesterol is converted mainly into coprostanol , a nonabsorbable sterol that is excreted in the feces. Although cholesterol is a steroid generally associated with mammals, the human pathogen Mycobacterium tuberculosis is able to completely degrade this molecule and contains a large number of genes that are regulated by its presence. Many of these cholesterol-regulated genes are homologues of fatty acid β-oxidation genes, but have evolved in such

5762-463: The domain may have ancestrally acted as a spacer to push the receptor beyond the extracellular matrix . The single transmembrane domain of 22 (mostly) non-polar residues crosses the plasma membrane in a single alpha helix . The cytosolic C-terminal domain contains ~50 amino acids, including a signal sequence important for localizing the receptors to clathrin-coated pits and for triggering receptor-mediated endocytosis after binding. Portions of

5848-448: The effects of statins and bisphosphonates on bone , muscle , and macrophages . On the basis of these findings, it has been suggested that the ERRα should be de-orphanized and classified as a receptor for cholesterol. Within cells, cholesterol is also a precursor molecule for several biochemical pathways . For example, it is the precursor molecule for the synthesis of vitamin D in

5934-405: The enzymes that use substrate presentation as a mechanism of their activation. Phospholipase D2 ( PLD2 ) is a well-defined example of an enzyme activated by substrate presentation. The enzyme is palmitoylated causing the enzyme to traffic to cholesterol dependent lipid domains sometimes called " lipid rafts ". The substrate of phospholipase D is phosphatidylcholine (PC) which is unsaturated and

6020-414: The epidermis. Steroid sulfate sulfatase then decreases its concentration in the stratum corneum, the outermost layer of the epidermis. The relative abundance of cholesterol sulfate in the epidermis varies across different body sites with the heel of the foot having the lowest concentration. Cholesterol is recycled in the body. The liver excretes cholesterol into biliary fluids, which are then stored in

6106-456: The highly acidic interior of the endosome . The exact mechanism of interaction between the class A repeats and ligand (LDL) is unknown, but it is thought that the repeats act as "grabbers" to hold the LDL. Binding of ApoB requires repeats 2-7 while binding ApoE requires only repeat 5 (thought to be the ancestral repeat). Next to the ligand binding domain is an EGF precursor homology domain (EGFP domain). This shows approximately 30% homology with

6192-407: The lipid mortar, a water-impermeable barrier that prevents evaporative water loss. As a rule of thumb, the epidermal lipid matrix is composed of an equimolar mixture of ceramides (≈50% by weight), cholesterol (≈25% by weight), and free fatty acids (≈15% by weight), with smaller quantities of other lipids also being present. Cholesterol sulfate reaches its highest concentration in the granular layer of

6278-461: The low-density lipoprotein ( LDL ) receptor and HMG-CoA reductase . The LDL receptor scavenges circulating LDL from the bloodstream, whereas HMG-CoA reductase leads to an increase in endogenous production of cholesterol. A large part of this signaling pathway was clarified by Dr. Michael S. Brown and Dr. Joseph L. Goldstein in the 1970s. In 1985, they received the Nobel Prize in Physiology or Medicine for their work. Their subsequent work shows how

6364-440: The majority of cholesterol is ingested or synthesized by hepatocytes and transported in the blood to peripheral cells. The levels of cholesterol in peripheral tissues is dictated by a balance of uptake and export. Under normal conditions, brain cholesterol is separate from peripheral cholesterol, i.e., the dietary and hepatic cholesterol do not cross the blood brain barrier. Rather, astrocytes produce and distribute cholesterol in

6450-601: The membrane, so that both the amino-terminal transcription factor domain and the COOH-terminal regulatory domain face the cytoplasm . The two membrane-spanning helices are separated by a loop of about 30 amino acids that lies in the lumen of the ER. Two separate, site-specific proteolytic cleavages are necessary for release of the transcriptionally active amino-terminal domain. These cleavages are carried out by two distinct proteases , called site-1 protease ( S1P ) and site-2 protease ( S2P ). In addition to S1P and S2P,

6536-587: The membrane. The newly generated amino-terminal half of SREBP (which is the ‘business end' of the molecule) then goes on to be cleaved at site-2 that lies within its membrane-spanning helix. This is the work of S2P, an unusual metalloprotease. This releases the cytoplasmic portion of SREBP, which then travels to the nucleus where it activates transcription of target genes (e.g. LDL receptor gene) Absence of sterols activates SREBP, thereby increasing cholesterol synthesis. Insulin, cholesterol derivatives, T3 and other endogenous molecules have been demonstrated to regulate

6622-461: The order of 0.2 gram of phytosterols, which is not enough to have a significant impact on blocking cholesterol absorption. Phytosterols intake can be supplemented through the use of phytosterol-containing functional foods or dietary supplements that are recognized as having potential to reduce levels of LDL -cholesterol. In 2015, the scientific advisory panel of U.S. Department of Health and Human Services and U.S. Department of Agriculture for

6708-560: The population. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol, whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding-sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase and apolipoprotein C-III. Combined, these observations suggest that, as well as LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk. Overall, LDLR has

6794-493: The primary mode of entry for the Vesicular stomatitis virus in mice and humans. In addition, LDLR modulation is associated with early atherosclerosis-related lymphatic dysfunction. Synthesis of receptors in the cell is regulated by the level of free intracellular cholesterol; if it is in excess for the needs of the cell then the transcription of the receptor gene will be inhibited. LDL receptors are translated by ribosomes on

6880-467: The receptor folds back on itself to obtain a closed conformation and recycles to the cell surface. The rapid recycling of LDL receptors provides an efficient mechanism for delivery of cholesterol to cells. It was also reported that by association with lipoprotein in the blood, viruses such as hepatitis C virus , Flaviviridae viruses and bovine viral diarrheal virus could enter cells indirectly via LDLR-mediated endocytosis. LDLR has been identified as

6966-448: The regulated release of transcriptionally active SREBP requires the cholesterol-sensing protein SREBP cleavage-activating protein ( SCAP ), which forms a complex with SREBP owing to interaction between their respective carboxy-terminal domains. SCAP, in turn, can bind reversibly with another ER-resident membrane protein, INSIG. In the presence of sterols, which bind to INSIG and SCAP, INSIG and SCAP also bind one another. INSIG always stays in

7052-471: The risk of cardiovascular disease . François Poulletier de la Salle first identified cholesterol in solid form in gallstones in 1769. In 1815, chemist Michel Eugène Chevreul named the compound "cholesterine". The word cholesterol comes from Ancient Greek chole- ' bile ' and stereos 'solid', followed by the chemical suffix -ol for an alcohol . Cholesterol is essential for all animal life. While most cells are capable of synthesizing it,

7138-554: The risk of related diseases. Individuals with disruptive mutations (defined as nonsense , splice site , or indel frameshift ) in LDLR have an average LDL-cholesterol of 279 mg/dL , compared with 135 mg/dL for individuals with neither disruptive nor deleterious mutations. Disruptive mutations were 13 times more common in individuals with early-onset myocardial infarction or coronary artery disease than in individuals without either disease. The LDLR gene resides on chromosome 19 at

7224-404: The synthesis of cholesterol de novo , according to its presence inside the cell. A cell with abundant cholesterol will have its LDL receptor synthesis blocked, to prevent new cholesterol in LDL particles from being taken up. Conversely, LDL receptor synthesis proceeds when a cell is deficient in cholesterol. When this process becomes unregulated, LDL particles without receptors begin to appear in

7310-537: The up-regulation of SREBP-1c and fatty acid synthase (FAS) in HepG2 cells elicited by FFAs treatment. Moreover, FGF21 could inhibit the transcriptional levels of the key genes involved in processing and nuclear translocation of SREBP-1c, and decrease the protein amount of mature SREBP-1c. Unexpectedly, overexpression of SREBP-1c in HepG2 cells could also inhibit the endogenous FGF21 transcription by reducing FGF21 promoter activity. SREBP-1c has also been shown to upregulate in

7396-467: Was found to be used in almost all organisms from bacteria to human beings and regulates a wide range of processes ranging from development to neurodegeneration. A feature of the SREBP pathway is the proteolytic release of a membrane-bound transcription factor, SREBP. Proteolytic cleavage frees it to move through the cytoplasm to the nucleus. Once in the nucleus, SREBP can bind to specific DNA sequences (the sterol regulatory elements or SREs) that are found in

#77922